U.S. Lawmaker Takes Drugs Chief to Task for Not Doing More on Drug Shortages

Sen. Richard Blumenthal (D-Conn.) March 29 called the U.S. Food and Drug Administration’s (FDA) response to drug shortages “inadequate,” saying lawmakers need to give the agency more tools and mandates to correct the issue. Blumenthal heads a bipartisan working group that is studying drug shortages and plans to release a list of proposals to address the issue “in the next few days,” he said during a Senate Health, Education, Labor, & Pensions (HELP) Committee hearing on FDA user fee programs.
International Pharmaceutical Regulatory Monitor